Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T12:00:37.610Z Has data issue: false hasContentIssue false
  • English
  • Français

Coronavirus disease 2019 convalescent children: outcomes after congenital heart surgery

Part of: Infectious

Published online by Cambridge University Press:  28 October 2021

Shreedhar S. Joshi Open the ORCID record for Shreedhar S. Joshi [Opens in a new window] ,
Manaswini Keshava ,
Keshava S. Murthy ,
Ganesh Sambandamoorthy ,
Riyan Shetty ,
Balasubramanian Shanmugasundaram ,
Sudesh Prabhu Open the ORCID record for Sudesh Prabhu [Opens in a new window] ,
Rajesh Hegde  and
Vijay S. Richard
Shreedhar S. Joshi*
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Manaswini Keshava
Affiliation:
M S Ramaiah Medical College, Bangalore, India
Keshava S. Murthy
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Ganesh Sambandamoorthy
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Riyan Shetty
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Balasubramanian Shanmugasundaram
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Sudesh Prabhu
Affiliation:
Department of Paediatric Cardiac Surgery, Narayana Institute of Cardiac Sciences, Bangalore, India
Rajesh Hegde
Affiliation:
Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India
Vijay S. Richard
Affiliation:
Department of Hospital Infection Control, Narayana Institute of Cardiac Sciences, Bangalore, India
*
Author for correspondence: Dr S. S. Joshi, MD., DM., FCA., FTEE (EACVI, NBE), Senior Consultant Cardiac Anaesthesia, Department of Anaesthesia and Intensive Care, Narayana Institute of Cardiac Sciences, Bangalore, India. Tel: +91-9740067381. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Children with exposure to coronavirus disease 2019 in recent times (asymptomatic or symptomatic infection) approaching congenital heart surgery programme are in increasing numbers. Understanding outcomes of such children will help risk-stratify and guide optimisation prior to congenital heart surgery.

Objective:

The objective of the present study was to determine whether convalescent coronavirus disease 2019 children undergoing congenital heart surgery have any worse mortality or post-operative outcomes.

Design:

Consecutive children undergoing congenital heart surgery from Oct 2020 to May 2021 were enrolled after testing for reverse transcription-polymerase chain reaction or rapid antigen test and immunoglobulin G antibody prior to surgery. Convalescent coronavirus disease 2019 was defined in any asymptomatic patient positive for immunoglobulin G antibodies and negative for reverse transcription-polymerase chain reaction or rapid antigen test anytime 6 weeks prior to surgery. Control patients were negative for any of the three tests. Mortality and post-operative outcomes were compared among the groups.

Results:

One thousand one hundred and twenty-nine consecutive congenital heart surgeries were stratified as convalescence and control. Coronavirus disease 2019 Convalescent (n = 349) and coronavirus disease 2019 control (n = 780) groups were comparable for all demographic and clinical factors except younger and smaller kids in control. Convalescent children had no higher mortality, ventilation duration, ICU and hospital stay, no higher support with extracorporeal membrane oxygenation, high flow nasal cannula, no higher need for re-intubations, re-admissions, and no higher infections as central line-associated bloodstream infection, sternal site infection, and ventilator-associated pneumonia on comparison with coronavirus disease 2019 control children.

Conclusions:

Convalescent coronavirus disease 2019 does not have any unfavourable outcomes as compared to coronavirus disease 2019 control children. Positive immunoglobulin G antibody screening prior to surgery is suggestive of convalescence and supports comparable outcomes on par with control peers.

Keywords

Coronavirus disease 2019 convalescent childrencongenital heart surgerylong coronavirus disease 2019 childrencoronavirus disease 2019 cardiopulmonary bypasscoronavirus disease 2019 heart lung
Type
Original Article
Information
Cardiology in the Young , Volume 32 , Issue 9 , September 2022 , pp. 1469 - 1474
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Protopapas, EM, Rito, ML, Vida, VL, et al. Early impact of the COVID-19 pandemic on congenital heart surgery programs across the world: assessment by a global multi-cocietal consortium. World J Pediatr Congenit Heart Surg 2020; 11: 689–696.CrossRefGoogle ScholarPubMed
Choubey, M, Ramakrishnan, S, Sachdeva, S, et al. Impact of COVID-19 pandemic on pediatric cardiac services in India. Ann Pediatr Cardiol 2021; 14: 260.Google ScholarPubMed
Bloise, S, Marcellino, A, Testa, A, et al. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur J Pediatr 2021; 180: 3335–3342.CrossRefGoogle ScholarPubMed
Gupta, N, Agrawal, S, Ish, P, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis 2020; 90: 193–196.Google Scholar
Zimmermann, P, Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2021; 106: 429–439.CrossRefGoogle Scholar
Preston, LE, Chevinsky, JR, Kompaniyets, L, et al. Characteristics and disease severity of US children and adolescents diagnosed with COVID-19. JAMA Netw Open 2021; 4: e215298.CrossRefGoogle ScholarPubMed
Wojcik, BM, Rajab, TK, Newman, S, Jaggers, J, Mitchell, MB. COVID-19 testing, surgical prioritization, and reactivation in a congenital cardiac surgery program. World J Pediatr Congenit Heart Surg 2021; 12: 150–151.CrossRefGoogle Scholar
Stephens, EH, Dearani, JA, Guleserian, KJ, et al. COVID-19: crisis management in congenital heart surgery. World J Pediatr Congenit Heart Surg 2020; 11: 395–400.Google ScholarPubMed
Mina, MJ, Andersen, KG. COVID-19 testing: one size does not fit all. Science 2021; 371: 126–127.CrossRefGoogle Scholar
Adler, AC, Shah, AS, Blumberg, TJ, et al. Symptomatology and racial disparities among children undergoing universal preoperative COVID-19 screening at three US children’s hospitals: early pandemic through resurgence. Paediatr Anaesth 2021; 31: 368–371.CrossRefGoogle ScholarPubMed
Collaborative, C. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396: 27–38. DOI 10.1016/S0140-6736(20)31182-X.Google Scholar
Haiduc, AA, Ogunjimi, M, Shammus, R, et al. COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks. Cardiol Young 2020; 31: 233–240. DOI 10.1017/S1047951120003741.CrossRefGoogle ScholarPubMed
Haji Esmaeil Memar, E, Pourakbari, B, Gorgi, M, et al. COVID-19 and congenital heart disease: a case series of nine children. World J Pediatr 2021; 17: 71–78.CrossRefGoogle ScholarPubMed
Ley-Vega, L. Potential heart problems in convalescent COVID-19 children: alert from a Cuban study. MEDICC Rev 2021; 23: 76–77.CrossRefGoogle ScholarPubMed
Cuppari, C, Ceravolo, G, Ceravolo, MD, et al. Covid-19 and cardiac involvement in childhood: state of the art. J Biol Regul Homeost Agents 2020; 34: 121–125.Google ScholarPubMed
Sandoval, N, Carreño, M, Novick, WM, et al. Tetralogy of fallot repair in developing countries: international quality improvement collaborative. Ann Thorac Surg 2018; 106: 1446–1451.Google ScholarPubMed
Dilli, D, Tasoglu, I. Perioperative care of the newborns with CHDs in the time of COVID-19. Cardiol Young 2020; 30: 946–954.CrossRefGoogle ScholarPubMed
Radke, RM, Frenzel, T, Baumgartner, H, Diller, GP. Adult congenital heart disease and the COVID-19 pandemic. Heart 2020; 106: 1302–1309.CrossRefGoogle ScholarPubMed
Schwerzmann, M, Ruperti-Repilado, FJ, Baumgartner, H, et al. Clinical outcome of COVID-19 in patients with adult congenital heart disease. Heart 2021; 0: 1–7.Google Scholar
Cleary, A, Chivers, S, Daubeney, PE, Simpson, JM. Impact of COVID-19 on patients with congenital heart disease. Cardiol Young 2020; 31: 163–165.CrossRefGoogle ScholarPubMed
Broberg, CS, Kovacs, AH, Sadeghi, S, et al. COVID-19 in adults with congenital heart disease. J Am Coll Cardiol 2021; 77: 1644–1655.CrossRefGoogle ScholarPubMed
Sachdeva, S, Ramakrishnan, S, Choubey, M, et al. Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: a multicentric study from India. Ann Pediatr Cardiol 2021; 14: 269.Google ScholarPubMed
Pierce, CA, Preston-Hurlburt, P, Dai, Y, et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med 2020; 12: eabd5487.Google ScholarPubMed
Wu, Q, Xing, Y, Shi, L, et al. Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics 2020; 146: e20200961. DOI 10.1542/peds.2020-0961.CrossRefGoogle ScholarPubMed
Miller, A, Reandelar, MJ, Fasciglione, K, Roumenova, V, Li, Y, Otazu, GH. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv 2020. DOI 10.1101/2020.03.24.20042937.Google Scholar
Riccò, M, Gualerzi, G, Ranzieri, S, Luigi Bragazzi, N. Stop playing with data: there is no sound evidence that bacille calmette-guérin may avoid SARS-CoV-2 infection for now. Acta Biomedica 2020; 91: 207–213.Google Scholar
Bansal, N, Azeka, E, Neunert, C, et al. Multisystem inflammatory syndrome associated with COVID-19 anti-thrombosis guideline of care for children by action. Pediatr Cardiol 2021; 1: 1.Google Scholar
Goldenberg, NA, Sochet, A, Albisetti, M, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost 2020; 18: 3099–3105.CrossRefGoogle ScholarPubMed
Loi, M, Branchford, B, Kim, J, Self, C, Nuss, R. COVID-19 anticoagulation recommendations in children. Pediatr Blood Cancer 2020; 67: e28485.Google ScholarPubMed
Ruel, M, Chan, V, Boodhwani, M, et al. How detrimental is reexploration for bleeding after cardiac surgery? J Thorac Cardiovasc Surg 2017; 154: 927–935.CrossRefGoogle ScholarPubMed
Yang, HS, Costa, V, Racine-Brzostek, SE, et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open 2021; 4: e214302.CrossRefGoogle ScholarPubMed
Atalay, A, Soran Türkcan, B, Taşoğluİ, İ, et al. Management of congenital cardiac surgery during COVID-19 pandemic. Cardiol Young 2020; 30: 1797–1805.CrossRefGoogle ScholarPubMed
Kotlyar, AM, Grechukhina, O, Chen, A, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224: 35–53.e3.CrossRefGoogle ScholarPubMed
Falsaperla, R, Giacchi, V, Lombardo, G, et al. Neonates born to COVID-19 mother and risk in management within 4 weeks of life: a single-center experience, Systematic review, and meta-analysis. Am J Perinatol 2021; 38: 1010–1022. DOI 10.1055/s-0041-1729557.Google ScholarPubMed
Flannery, DD, Gouma, S, Dhudasia, MB, et al. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr 2021; 175: 594–600.CrossRefGoogle ScholarPubMed
Arkhipova-Jenkins, I, Helfand, M, Armstrong, C, et al. Antibody response after SARS-CoV-2 infection and implications for immunity. Ann Intern Med 2021; 174: 811–821.CrossRefGoogle ScholarPubMed
Sanil, Y, Misra, A, Safa, R, et al. Echocardiographic indicators associated with adverse clinical course and cardiac sequelae in multisystem inflammatory syndrome in children with coronavirus disease 2019. J Am Soc Echocardiog 2021; 34: 862–876. DOI 10.1016/j.echo.2021.04.018.CrossRefGoogle ScholarPubMed
ScienceDaily. Post-COVID syndrome severely damages children’s hearts: “Immense inflammation” causing cardiac blood vessel dilation. Retrieved June 10, 2021, fromhttps://www.sciencedaily.com/releases/2020/09/200904125111.htm Google Scholar
Ludvigsson, JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr 2021; 110: 914–921.CrossRefGoogle ScholarPubMed
Huang, L, Cao, B. Post-acute conditions of patients with COVID-19 not requiring hospital admission. In The Lancet Infectious Diseases, 2021, 10.1016/s1473-3099(21)00225-5.Google Scholar
Lerner, AM, Robinson, DA, Yang, L, et al. Toward understanding COVID-19 recovery: National Institutes of Health workshop on postacute COVID-19. Ann Intern Med 2021; 174: 999–1003. DOI 10.7326/m21-1043.CrossRefGoogle ScholarPubMed
Medical Humanities. The Future is Convalescence: Rethinking Recovery and the End of Covid-19. Retrieved June 22, 2021, from https://blogs.bmj.com/medical-humanities/2021/01/07/the-future-is-convalescence-rethinking-recovery-and-the-end-of-covid-19/ Google Scholar
Lund, LC, Hallas, J, Nielsen, H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis 2021; 21: 1373–1382. DOI 10.1016/s1473-3099(21)00211-5.CrossRefGoogle Scholar